![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/06/Building-a-Global-Legacy-in-CRDMO-Services-pdf.jpg)
Building a Global Legacy in CRDMO Services
By Syngene
With over 30 years of experience, Syngene has served more than 2000 customers, including over 450 active clients, ranging from leading multinationals to start-ups and academic institutions. Syngene’s facilities comply with global regulatory standards, including USFDA and EMA.
Our biologics portfolio includes diverse molecules and expression systems. We are in a 10-year partnership with Zoetis for monoclonal antibodies in animal health.
Syngene’s expertise in the field is covered in this view point.
![](https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/06/Building-a-Global-Legacy-in-CRDMO-Services-pdf.jpg)